Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths

Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The FDA has ruled that this a Class I recall.

Video of SNMMI President Cathy Cutler explaining the efforts to get U.S. production started for Mo-99 for a domestic supply of nuclear imaging isotopes. #RSNA #SNMMI #RSNA24 #RSNA2024 #isotopeshortage

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging

Society of Nuclear Medicine and Molecular Imaging President, Cathy Cutler, explains the long road to jump-starting a new U.S. domestic supply of imaging isotopes.

healthcare value value-based care money dollar

Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

BioZorb 3D bioabsorbable marker Hologic

Hologic recalling breast care device after 252 injuries, slew of patient lawsuits

More than 100 plaintiffs have now sued the Marlborough, Massachusetts-based mammography-maker, claiming they suffered injuries and emotional distress stemming from implantation of the BioZorb radiographic marker. 

AI in healthcare

Most patients want to know if AI is involved in their care

“With this signal about the public’s preference for notification, the question for health systems and policymakers is not whether to notify patients but when and how.” 

Surgeons in Houston have performed the world’s first successful human implant of BiVACOR’s Total Artificial Heart (TAH) technology. The procedure was completed July 9, 2024, at The Texas Heart Institute at Baylor St. Luke’s Medical Center. It was part of an early feasibility study (EFS) first approved by the U.S. Food and Drug Administration (FDA) back in December 2023.

‘Incredibly rewarding’: FDA expands total artificial heart study after early success

An additional 15 patients will now receive BiVacor's titanium total artificial heart technology as they wait for a permanent transplant.

Congress dome capitol Washington

Congress reaches deal to partially blunt Medicare pay cut, ditches prior authorization reform

UPDATED Dec. 23: Lawmakers have now ditched the previously agreed-upon deal and passed a slimmed-down version at the urging of President-elect Trump. 

Prenuvo's newest location in New York City.

Whole-body MRI startup Prenuvo’s recent ‘milestone’ would mark $250M in revenue

The California-based company said Tuesday that it has scanned 100,000 patients, charging $2,499 a pop for the 60-minute elective exam.